$FABC Cashflow Statement | Understand Stock

$FABC

$2.04 +$0.08 (4.08%) Close

$FABC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Loss on disposal of fixed asset
Loss on impairment of long-lived assets
Stock-based compensation
Shares issued for services
Series H-7 preferred stock waiver
Series I financing costs
Change in fair value - derivative liability
Change in fair value of warrant liability
Amortization of right-of-use asset
Bad debt expense
Unrealized loss on digital assets
Unrealized gain on marketable securities
Impairment of inventory and prepaid
Realized gain on marketable securities
Impairment of inventory
Realized loss on sale of fixed assets
Impairment of prepaid inventory
Vendor settlements
Change in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Deposits and other assets
Accounts payable
Accrued expenses and other current liabilities
Contract liability
Lease obligations - operating leases

Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Purchase of marketable securities, net
Proceeds from sale of marketable securities, net
Purchase of digital assets
Purchase of marketable securities
Proceeds from sale of fixed assets
Purchase of intangible assets
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Repayments of debt
Proceeds from exercise of warrants, net of fees
Proceeds from exercise of stock options
Proceeds from issuance of Common Stock, net of fees and expenses
Proceeds from private placement of preferred stock, net of transaction costs

Proceeds from sale of preferred stock (I), net of transaction costs
Proceeds from exercise of Series H-7 Preferred warrants
Payment of preferred stock redemption (Series H-7)
Payment of shares buyback
Repurchase of cash-settled restricted stock
Net cash used in financing activities
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of cash and non-cash transactions:
Restricted Stock issued previously accrued
Accrued fixed assets
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets
Initial fair value of warranty liability
Initial fair value of derivative liability
Deemed Dividend H-5 Warrants
Deemed dividend Series H-5 Warrants
Fixed asset additions included in accounts payable and accrued expenses
Accrual of Series H-7 convertible preferred stock dividends
Deemed dividend Series H-7 warrants
Accretion of discounts to redemption value of H-7 convertible preferred stock
Accretion of discounts to redemption value of I convertible preferred stock
Accrued Series H-7 preferred stock redemption payable
Accrual of Series I Convertible Preferred Stock Dividends
Non-cash redemption of Series H-7 preferred stock
Reclassification of warrant liability to equity (H-7)
Reclassification of warrant liability to equity (I)
Accrued waiver fee related to Series H-7 preferred stock
Prepaid insurance financed through accrued expenses

Supplemental disclosure of restricted cash:
Cash paid for interest
Restricted Stock for service, vested not issued
Cash and cash equivalents
Restricted cash
Total cash, cash equivalents and restricted cash

Comments